BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22994189)

  • 21. Implementation of tobacco cessation quitline practices in the United States and Canada.
    Saul JE; Bonito JA; Provan K; Ruppel E; Leischow SJ
    Am J Public Health; 2014 Oct; 104(10):e98-105. PubMed ID: 25122024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanding access to nicotine replacement therapy through Minnesota's QUITLINE partnership.
    Schillo BA; Wendling A; Saul J; Luxenberg MG; Lachter R; Christenson M; An LC
    Tob Control; 2007 Dec; 16 Suppl 1(Suppl 1):i37-41. PubMed ID: 18048630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knowledge and beliefs about electronic cigarettes among quitline cessation staff.
    Cummins S; Leischow S; Bailey L; Bush T; Wassum K; Copeland L; Zhu SH
    Addict Behav; 2016 Sep; 60():78-83. PubMed ID: 27100472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The reach ratio--a new indicator for comparing quitline reach into smoking subgroups.
    Campbell HS; Baskerville NB; Hayward LM; Brown KS; Ossip DJ
    Nicotine Tob Res; 2014 Apr; 16(4):491-5. PubMed ID: 24311698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do state characteristics matter? State level factors related to tobacco cessation quitlines.
    Keller PA; Koss KJ; Baker TB; Bailey LA; Fiore MC
    Tob Control; 2007 Dec; 16 Suppl 1(Suppl 1):i75-80. PubMed ID: 18048637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of smoking reduction strategies among U.S. tobacco quitlines.
    Asfar T; Ebbert JO; Klesges RC; Klosky JL
    Addict Behav; 2012 Apr; 37(4):583-6. PubMed ID: 22301531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 2009 US federal cigarette tax increase and quitline utilization in 16 states.
    Bush T; Zbikowski S; Mahoney L; Deprey M; Mowery PD; Magnusson B
    J Environ Public Health; 2012; 2012():314740. PubMed ID: 22649463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effect of Survey Nonresponse on Quitline Abstinence Rates: Implications for Practice.
    Lien RK; Schillo BA; Goto CJ; Porter L
    Nicotine Tob Res; 2016 Jan; 18(1):98-101. PubMed ID: 25646347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tobacco cessation quitline spending in 2005 and 2006: what state-level factors matter?
    Keller PA; Beyer EJ; Baker TB; Bailey LA; Fiore MC
    Int J Environ Res Public Health; 2009 Jan; 6(1):259-66. PubMed ID: 19440282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Association between Quitline Characteristics and Smoking Cessation by Educational Attainment, Income, Race/Ethnicity, and Sex.
    Colston DC; Simard BJ; Xie Y; McLeod MC; Elliott MR; Thrasher JF; Fleischer NL
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33806747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cessation among state quitline participants with a mental health condition.
    Kerkvliet JL; Wey H; Fahrenwald NL
    Nicotine Tob Res; 2015 Jun; 17(6):735-41. PubMed ID: 25385874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of a state-sponsored mass media campaign on use of telephone quitline and web-based cessation services.
    Duke JC; Mann N; Davis KC; MacMonegle A; Allen J; Porter L
    Prev Chronic Dis; 2014 Dec; 11():E225. PubMed ID: 25539129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Safety Net Tobacco Use Cessation Resource: Quitline Service Usage, 2019.
    Tetlow SM; Zhang L; Borowiecki M; Kim Y; Gentzke AS; Wang TW; Cornelius ME; Hawkins NA
    Prev Chronic Dis; 2023 Sep; 20():E84. PubMed ID: 37769250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kentucky's Smoking Cessation Quitline: Annual Estimated Return on Investment to Employers.
    Pauly N; Talbert J; Parsley S; Gray B; Hahn EJ
    Am J Health Promot; 2019 Feb; 33(2):285-288. PubMed ID: 29969913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effectiveness of adding weight control simultaneously or sequentially to smoking cessation quitlines: study protocol of a randomized controlled trial.
    Bush T; Lovejoy J; Javitz H; Magnusson B; Torres AJ; Mahuna S; Benedict C; Wassum K; Spring B
    BMC Public Health; 2016 Jul; 16():615. PubMed ID: 27443485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quitlines a tool for research and dissemination of evidence-based cessation practices.
    McAfee TA
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S357-67. PubMed ID: 18021911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Canadian tobacco packaging policy on quitline reach and reach equity.
    Baskerville NB; Hayward L; Brown KS; Hammond D; Kennedy RD; Campbell HS
    Prev Med; 2015 Dec; 81():243-50. PubMed ID: 26400639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Replicating state Quitline innovations to increase reach: findings from three states.
    Keller PA; Lien RK; Beebe LA; Parker J; Klein P; Lachter RB; Gillaspy S
    BMC Public Health; 2020 Jan; 20(1):7. PubMed ID: 31906908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and predictors of quitline enrollment following hospital referral in real-world clinical practice.
    Warlick C; Richter KP; Mussulman LM; Nazir N; Patel V
    J Subst Abuse Treat; 2019 Jun; 101():25-28. PubMed ID: 31174711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing reach of quitline services in a US state with comprehensive tobacco treatment.
    Woods SS; Haskins AE
    Tob Control; 2007 Dec; 16 Suppl 1(Suppl 1):i33-6. PubMed ID: 18048629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.